Osaic Holdings’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.7K | Sell |
7,450
-3,800
| -34% | -$34K | ﹤0.01% | 4481 |
|
|
2025
Q1 | $70.5K | Buy |
11,250
+7,958
| +242% | +$49.9K | ﹤0.01% | 4438 |
|
|
2024
Q4 | $26.7K | Buy |
3,292
+2,277
| +224% | +$18.5K | ﹤0.01% | 5105 |
|
|
2024
Q3 | $18.4K | Sell |
1,015
-1,200
| -54% | -$21.7K | ﹤0.01% | 5386 |
|
|
2024
Q2 | $22.8K | Buy |
2,215
+1,985
| +863% | +$20.4K | ﹤0.01% | 5215 |
|
|
2024
Q1 | $2.44K | Sell |
230
-49
| -18% | -$520 | ﹤0.01% | 6243 |
|
|
2023
Q4 | $2.55K | Sell |
279
-2,434
| -90% | -$22.2K | ﹤0.01% | 6336 |
|
|
2023
Q3 | $28.1K | Sell |
2,713
-1,538
| -36% | -$15.9K | ﹤0.01% | 5356 |
|
|
2023
Q2 | $59.4K | Buy |
4,251
+4,100
| +2,715% | +$57.3K | ﹤0.01% | 4816 |
|
|
2023
Q1 | $1.08K | Buy |
151
+1
| +0.7% | +$7 | ﹤0.01% | 6809 |
|
|
2022
Q4 | $2K | Sell |
150
-400
| -73% | -$5.33K | ﹤0.01% | 6633 |
|
|
2022
Q3 | $6K | Sell |
550
-12,011
| -96% | -$131K | ﹤0.01% | 6251 |
|
|
2022
Q2 | $106K | Sell |
12,561
-35,854
| -74% | -$303K | ﹤0.01% | 4376 |
|
|
2022
Q1 | $659K | Buy |
48,415
+42,747
| +754% | +$582K | ﹤0.01% | 2958 |
|
|
2021
Q4 | $112K | Buy |
5,668
+3,592
| +173% | +$71K | ﹤0.01% | 4501 |
|
|
2021
Q3 | $67K | Buy |
2,076
+853
| +70% | +$27.5K | ﹤0.01% | 4875 |
|
|
2021
Q2 | $41K | Hold |
1,223
| – | – | ﹤0.01% | 5183 |
|
|
2021
Q1 | $46K | Hold |
1,223
| – | – | ﹤0.01% | 4924 |
|
|
2020
Q4 | $41K | Hold |
1,223
| – | – | ﹤0.01% | 4676 |
|
|
2020
Q3 | $45K | Buy |
1,223
+473
| +63% | +$17.4K | ﹤0.01% | 4365 |
|
|
2020
Q2 | $25K | Buy |
+750
| New | +$25K | ﹤0.01% | 4642 |
|